Literature DB >> 16628730

Analysis of serum granulysin in patients with hematopoietic stem-cell transplantation: its usefulness as a marker of graft-versus-host reaction.

Masayuki Nagasawa1, Takeshi Isoda, Sukeyuki Itoh, Michiko Kajiwara, Tomohiro Morio, Norio Shimizu, Kazuyuki Ogawa, Kinya Nagata, Masataka Nakamura, Shuki Mizutani.   

Abstract

Granulysin is a newly identified CTL/NK cell-related cytotoxic protein, which is secreted in both constitutive and Ca-dependent manner. To evaluate its significance in stem-cell transplantation (SCT), serum granulysin was measured by newly established ELISA method in 26 patients undergoing SCT (21 allogeneic and 5 autologous). In the allogeneic SCT, granulysin was transiently increased in 3 weeks, which was not observed in autologous SCT. In acute GVHD, serum granulysin was markedly increased and correlated with the severity of GVHD. Elevation of granulysin was not necessarily associated with increase of sIL2R or IFN-gamma. In vitro, allospecific T cells released granulysin in an allo-specific manner, and it was correlated with allo-specific cytotoxic activity. These results indicate that increased release of granulysin presents alloreactivity and serum granulysin is useful as a marker of GVHD in SCT. 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628730     DOI: 10.1002/ajh.20570

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  Serum granulysin is elevated in patients with hemophagocytic lymphohistiocytosis.

Authors:  Masayuki Nagasawa; Kazuyuki Ogawa; Shinsaku Imashuku; Shuki Mizutani
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

2.  Decreased serum granulysin levels in childhood tuberculosis which reverse after therapy.

Authors:  Diana Di Liberto; Simona Buccheri; Nadia Caccamo; Serena Meraviglia; Amelia Romano; Paola Di Carlo; Lucina Titone; Francesco Dieli; Alan M Krensky; Alfredo Salerno
Journal:  Tuberculosis (Edinb)       Date:  2007-03-26       Impact factor: 3.131

3.  Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHD.

Authors:  Masayuki Nagasawa; Noriko Mitsuiki; Masakatsu Yanagimachi; Masahide Yamamoto; Tetsuya Fukuda; Osamu Miura; Ryutaro Oba; Akira Igarashi; Kinya Nagata; Tomohiro Morio
Journal:  Int J Hematol       Date:  2021-03-08       Impact factor: 2.490

4.  Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms.

Authors:  Nodoka Sekiguchi; Naoko Asano; Toshiro Ito; Kayoko Momose; Masanobu Momose; Fumihiro Ishida
Journal:  Int J Hematol       Date:  2012-08-14       Impact factor: 2.490

5.  Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin.

Authors:  Poonam Tewary; De Yang; Gonzalo de la Rosa; Yana Li; Michael W Finn; Alan M Krensky; Carol Clayberger; Joost J Oppenheim
Journal:  Blood       Date:  2010-07-21       Impact factor: 22.113

6.  Increased granulysin expression in peripheral blood cells of patients with primary biliary cirrhosis and its clinical implications.

Authors:  Cheng Qian; Sunxiao Chen; Dingkang Yao; Chuanyong Wu; Tingwang Jiang; Jinshan Ke; Ye Zhou; Mingli Gu; Bo Chen; Anmei Deng; Renqian Zhong
Journal:  J Clin Immunol       Date:  2008-06-28       Impact factor: 8.317

Review 7.  Biology and clinical relevance of granulysin.

Authors:  A M Krensky; C Clayberger
Journal:  Tissue Antigens       Date:  2009-03

8.  Granulysin-Bearing Cells in the Skin Lesions of Acute Graft-versus-Host Disease: Possible Mechanisms for Hypohidrosis in Graft-versus-Host Disease.

Authors:  Sadanori Furudate; Taku Fujimura; Yumi Kambayashi; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2013-04-05

Review 9.  Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions.

Authors:  Shih-Chi Su; Wen-Hung Chung
Journal:  Toxins (Basel)       Date:  2014-01-03       Impact factor: 4.546

10.  Antimicrobial Properties of an Immunomodulator - 15 kDa Human Granulysin.

Authors:  Hung-Mu Wei; Li-Chih Lin; Chiu-Feng Wang; Yi-Jang Lee; Yuan-Tsong Chen; You-Di Liao
Journal:  PLoS One       Date:  2016-06-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.